“…In fact, nocardiosis appears to be a rare infection in children (105)(106)(107) (20,108). However, there are increasing reports of breakthrough infections by TMP-SMX-susceptible Nocardia isolates in patients taking TMP-SMX prophylaxis (11,13,14,19,34,46,69,(108)(109)(110), creating some doubt about the utility of this agent for prevention of nocardiosis (34) (13,14,109), though nocardiosis has also been reported despite daily TMP-SMX prophylaxis (46). Data are limited on which to base recommendations for secondary prophylaxis.…”